Anastrozole: An aromatase inhibitor as a potential preventative agent in women at high risk of developing breast cancer.

被引：0

作者：

Buzdar, AU ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2002年 / 11卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1245S / 1245S

页数：1

共 50 条

[1] The effects of an aromatase inhibitor (anastrozole) or sulfatase inhibitor (STX64) on androgen concentrations in postmenopausal women with breast cancer.
Stanway, S. J.
Purohit, A.
Woo, L. L. W.
Stanczyk, F. Z.
Potter, B. V. L.
Folkherd, E. J.
Dowsett, M.
Coombes, R. C.
Reed, M. J.
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S189 - S189
[2] Anastrozole: A selective aromatase inhibitor for the treatment of breast cancer
Higa, GM
AlKhouri, N
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (05) : 445 - 452
[3] IBISII: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole
Cuzick, Jack
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) : 1377 - 1385
[4] Effect of Tamoxifen and Aromatase Inhibitors on the Risk of Fractures in Women with Breast Cancer.
Vestergaard, P.
Rejnmark, L.
Mosekilde, L.
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S297 - S297
[5] Polypharmacy and premature aromatase inhibitor (AI) discontinuation in older women with breast cancer.
Joyce, Elizabeth
Kidwell, Kelley M.
Stearns, Vered
Hayes, Daniel F.
Storniolo, Anna Maria
Henry, Norah Lynn
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[6] Preventative therapies for healthy women at high risk of breast cancer
Sestak, Ivana
[J]. CANCER MANAGEMENT AND RESEARCH, 2014, 6 : 423 - 430
[7] Psychological impact of genetic counseling on women at high risk of developing breast cancer.
Meiser, B
Butow, P
Barratt, A
Tucker, K
[J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A12 - A12
[8] Clinical dosage determination of a new aromatase inhibitor, anastrozole, in postmenopausal Japanese women with advanced breast cancer
Nomura, Y
Koyama, H
Ohashi, Y
Watanabe, H
[J]. CLINICAL DRUG INVESTIGATION, 2000, 20 (05) : 357 - 369
[9] Clinical Dosage Determination of a New Aromatase Inhibitor, Anastrozole, in Postmenopausal Japanese Women with Advanced Breast Cancer
Yasuo Nomura
Hiroki Koyama
Yasuo Ohashi
Hiroshi Watanabe
[J]. Clinical Drug Investigation, 2000, 20 : 357 - 369
[10] Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with breast cancer or at high risk of developing it
Sestak, I.
Harvie, M.
Howell, A.
Forbes, J. F.
Dowsett, M.
Cuzick, J. M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)

← 1 2 3 4 5 →